• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
MHE Testing in Real World Scenario.真实场景中的轻微肝性脑病检测
J Clin Exp Hepatol. 2018 Dec;8(4):438-440. doi: 10.1016/j.jceh.2018.04.010. Epub 2018 May 5.
2
Diagnosis of minimal hepatic encephalopathy.轻微肝性脑病的诊断
J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S54-9. doi: 10.1016/j.jceh.2014.06.005. Epub 2014 Jul 31.
3
Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis.用于诊断肝硬化患者轻微肝性脑病的临界闪烁频率测试
Turk J Gastroenterol. 2017 May;28(3):191-196. doi: 10.5152/tjg.2017.16618. Epub 2017 Mar 17.
4
Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.经颈静脉肝内门体分流术（TIPS）预测 TIPS 术后显性肝性脑病：临界闪烁频率比心理测试更准确。
Hepatology. 2014 Feb;59(2):622-9. doi: 10.1002/hep.26684.
5
Inhibitory control test for the detection of minimal hepatic encephalopathy in patients with cirrhosis of liver.用于检测肝硬化患者轻微肝性脑病的抑制控制测试。
J Clin Exp Hepatol. 2012 Dec;2(4):306-14. doi: 10.1016/j.jceh.2012.07.001. Epub 2012 Dec 16.
6
Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.临界闪烁频率在轻度肝性脑病患者中的价值。
Hepatology. 2007 Apr;45(4):879-85. doi: 10.1002/hep.21586.
7
Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy tests.经颈静脉肝内门体分流术后显性肝性脑病的预测：三种轻微肝性脑病检测方法的价值
JHEP Rep. 2023 Jun 28;5(9):100829. doi: 10.1016/j.jhepr.2023.100829. eCollection 2023 Sep.
8
Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study.肝硬化患者轻微肝性脑病不同诊断方式的评估：病例对照研究。
Clin Exp Hepatol. 2021 Sep;7(3):312-319. doi: 10.5114/ceh.2021.109292. Epub 2021 Sep 23.
9
Prevalence of minimal hepatic encephalopathy in cirrhotic patients.肝硬化患者中轻微型肝性脑病的患病率。
Ann Hepatol. 2011 Jun;10 Suppl 2:S40-4.
10
Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.临界闪烁频率和心理测肝性脑病评分在诊断轻度肝性脑病中的价值。
Gastroenterology. 2014 Apr;146(4):961-9. doi: 10.1053/j.gastro.2013.12.026. Epub 2013 Dec 21.

引用本文的文献

1
Minimal encephalopathy in hereditary hemorrhagic telangiectasia patients with portosystemic vascular malformations.患有门体静脉血管畸形的遗传性出血性毛细血管扩张症患者的轻微脑病
Orphanet J Rare Dis. 2024 Dec 21;19(1):484. doi: 10.1186/s13023-024-03493-3.
2
Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.应用连续反应时间法和门脉系统脑病综合征测试预测临床精神正常的肝硬化患者显性肝性脑病。
PLoS One. 2019 Dec 12;14(12):e0226283. doi: 10.1371/journal.pone.0226283. eCollection 2019.
3
UPDATE IN HEPATIC ENCEPHALOPATHY - PART II.肝性脑病的最新进展 - 第二部分。
J Clin Exp Hepatol. 2018 Dec;8(4):333-334. doi: 10.1016/j.jceh.2018.11.001. Epub 2018 Nov 29.

本文引用的文献

1
The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study.通过一项随机对照多模态干预验证的轻微肝性脑病连续反应时间测试：一项初步研究。
PLoS One. 2017 Oct 11;12(10):e0185412. doi: 10.1371/journal.pone.0185412. eCollection 2017.
2
The animal naming test: An easy tool for the assessment of hepatic encephalopathy.动物命名测试：肝性脑病评估的简便工具。
Hepatology. 2017 Jul;66(1):198-208. doi: 10.1002/hep.29146. Epub 2017 May 27.
3
Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study.使用Stroop脑病应用程序诊断轻微肝性脑病：一项基于美国多中心的、基于常模的研究。
Am J Gastroenterol. 2016 Jan;111(1):78-86. doi: 10.1038/ajg.2015.377. Epub 2015 Dec 8.
4
Hepatic encephalopathy treatment and its effect on driving abilities: A continental divide.肝性脑病的治疗及其对驾驶能力的影响：一条大陆分水岭。
J Hepatol. 2015 Jul;63(1):287-8. doi: 10.1016/j.jhep.2015.03.017. Epub 2015 Mar 18.
5
A survey of patterns of practice and perception of minimal hepatic encephalopathy: a nationwide survey in India.一项关于轻微肝性脑病的实践模式与认知的调查：印度全国性调查
Saudi J Gastroenterol. 2014 Sep-Oct;20(5):304-8. doi: 10.4103/1319-3767.141692.
6
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.慢性肝病中的肝性脑病：美国肝病研究协会和欧洲肝脏研究协会2014年实践指南
Hepatology. 2014 Aug;60(2):715-35. doi: 10.1002/hep.27210. Epub 2014 Jul 8.
7
Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.基于智能手机的Stroop测试EncephalApp用于隐匿性肝性脑病诊断的验证
Clin Gastroenterol Hepatol. 2015 Oct;13(10):1828-1835.e1. doi: 10.1016/j.cgh.2014.05.011. Epub 2014 May 17.
8
Diagnosis of covert hepatic encephalopathy without specialized tests.无需专门检测的隐匿性肝性脑病诊断
Clin Gastroenterol Hepatol. 2014 Aug;12(8):1384-1389.e2. doi: 10.1016/j.cgh.2013.12.020. Epub 2013 Dec 19.
9
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).肝硬化患者因肝性脑病住院的特征、风险因素和死亡率，伴有和不伴有慢加急性肝衰竭（ACLF）。
J Hepatol. 2014 Feb;60(2):275-81. doi: 10.1016/j.jhep.2013.10.004. Epub 2013 Oct 12.
10
Cognitive dysfunction in cirrhosis is associated with falls: a prospective study.肝硬化患者的认知功能障碍与跌倒有关：一项前瞻性研究。
Hepatology. 2012 Jun;55(6):1922-30. doi: 10.1002/hep.25554. Epub 2012 Apr 4.

真实场景中的轻微肝性脑病检测

MHE Testing in Real World Scenario.

作者信息

Lauridsen Mette M, Vilstrup Hendrik

机构信息

Department of Gastroenterology and Hepatology, Hospital of South West Jutland, Finsensgade 35, 6700 Esbjerg, Denmark.

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Nørrebrogade 44, Aarhus, Denmark.

出版信息

J Clin Exp Hepatol. 2018 Dec;8(4):438-440. doi: 10.1016/j.jceh.2018.04.010. Epub 2018 May 5.

DOI:10.1016/j.jceh.2018.04.010
PMID:30564002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6286437/
Abstract

Professional MHE awareness is high but when it comes to psychometric testing for MHE the real world scenario is characterized by hesitation and testing is offered only to selected cirrhosis patients. The hesitation is rooted in doubts about which tests to use, lack of knowledge about treatment benefits, and uncertainty about the tests' ability to identify patients who will benefit from anti-HE treatment. Thus, the majority of MHE patients do not receive the available efficient anti-HE treatment. This mini-review attempts to quell some of these doubts.

摘要

专业人士对轻微肝性脑病（MHE）的认知度很高，但在针对MHE进行心理测量测试时，现实情况是存在犹豫，并且仅对部分肝硬化患者进行测试。这种犹豫源于对使用何种测试的怀疑、对治疗益处缺乏了解以及对测试识别能从抗肝性脑病治疗中获益患者的能力存在不确定性。因此，大多数MHE患者未接受现有的有效抗肝性脑病治疗。本小型综述试图消除其中一些疑虑。